Asensus Surgical, Inc. ASXC
At closeAug 21, 2024, 4:00 PM EDT
52-week range unavailable
- Market cap
- 94.92M
- Revenue (ttm)
- 9.85M
- Shares out
- 272.84M
- Forward P/E
- -2.68
- Volume
- 3.94M
- Open
- 0.346
- Previous close
- 0.3479
- Day's range
- 0.346 – 0.3495
- Beta
- 1.38
- Analysts
- Hold
- Price target
- 0.35 (+0.6%)
- Earnings date
- Aug 13, 2024
2Y -0.2196 (-38.70%)
Key statistics
- Enterprise value
- 92.26M
- PEG ratio
- 0.00
- Price / sales
- 9.64
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 104.20%
- Free cash flow
- -1.87M
- Total cash
- 7.78M
- Total debt
- 5.12M
- Return on equity
- -334.02%
- Short % of float
- 4.23%
- 50-day average
- 0.328538
- 200-day average
- 0.289417
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Aug 13, 2024
Expected Aug 13, 2024. Consensus EPS estimate -0.04.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2024 | Jun 1, 2024 | -0.05 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -0.05 | — | — | — |
| Mar 21, 2024 | Dec 1, 2023 | -0.05 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -0.07 | — | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -0.08 | — | — | — |
| May 11, 2023 | Mar 1, 2023 | -0.07 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2023 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 10, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Mar 5, 2023 | HC Wainwright & Co. | main | — | Buy |
| Feb 21, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Jan 9, 2023 | HC Wainwright & Co. | reit | — | Buy |
About Asensus Surgical, Inc.
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- asensus.com
News
Asensus Surgical Announces Closing of Acquisition by KARL STORZ 
Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates 
Asensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call Transcript 
Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024 
Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned 
Independent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote “FOR” the Pending Merger with KARL STORZ 
Glass Lewis Recommends Asensus Surgical Stockholders Vote “FOR” Proposals Relating to Proposed Merger with KARL STORZ 
Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology 
Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program 
Asensus Surgical (ASXC) Announces New Hospital Tie-Up on Senhance
Your note
Sign in to keep a note on ASXC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.32% | 11,393,457 | 5.75M | Jun 29, 2023 |
| Blackrock Inc. | 1.40% | 3,699,987 | 1.87M | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.80% | 2,108,122 | 1.06M | Jun 29, 2023 |
| Masters Capital Management, LLC | 0.76% | 2,000,000 | 1.01M | Jun 29, 2023 |
| Millennium Management Llc | 0.65% | 1,720,676 | 868.94K | Jun 29, 2023 |
| State Street Corporation | 0.36% | 952,929 | 481.23K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.93% | 7,734,650 | 3.91M | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 1.21% | 3,205,099 | 1.62M | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.45% | 1,199,060 | 623.51K | May 30, 2023 |
| Mutual Fund Ser Tr-AlphaCentric Robotics & Automation Fund | 0.19% | 500,000 | 252.50K | Jun 29, 2023 |
| Fidelity Total Market Index Fund | 0.16% | 410,079 | 213.24K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.13% | 331,322 | 172.29K | May 30, 2023 |